| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $442.0M | +38.0% |
| Cost of Revenue | $330.5M | +58.8% |
| Gross Profit | $111.5M | -0.5% |
| R&D Expense | $17.2M | +21.1% |
| SG&A Expense | $36.2M | +1.7% |
| Operating Income | $48.0M | -8.4% |
| Interest Expense | $2.7M | +107.7% |
| Pre-tax Income | $73.0M | -13.6% |
| Income Tax | -$200K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $671.4M | +233.7% |
| Accounts Receivable | $80.0M | +61.9% |
| Inventory | $161.6M | -47.3% |
| Current Assets | $1.02B | +48.1% |
| Total Assets | $1.09B | +37.3% |
| Current Liabilities | $346.8M | -26.4% |
| Long-term Debt | $472.5M | +427.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $37.0M | +306.6% |
| Capital Expenditures | $4.1M | +156.3% |
| Investing Cash Flow | -$4.1M | -156.3% |
| Financing Cash Flow | $437.1M | +3044.6% |
| Free Cash Flow | $32.9M | +338.7% |
| -300.0% |
| Net Income | $73.2M | -13.3% |
| EPS (Basic) | $4.49 | -19.1% |
| EPS (Diluted) | $4.47 | -17.8% |
| Total Liabilities |
| $932.0M |
| +22.0% |
| Stockholders' Equity | $161.4M | +399.7% |